Audio Described Videos from Talking Books
The Visually
Impaired Service Team
Clinical
Trial for Wet Macular Patients
|
Audio Described Videos from Talking Books The Perkins Library is pleased to offer
over 200 audio described videos for loan to Library borrowers. Described
videos provide narration of key visual elements, such as characters'
actions, costuming, gestures, and facial expressions, as well as
scene changes and onscreen text. These descriptions are heard during
the natural pauses in dialoque, and the result is a finished soundtrack
that enables visually impaired viewers to fully understand the film
through listening. Video selections include comedy, romance, adventure,
musicals, and children's films. A standard TV and VCR are required
to access described videos. No special equipment is required. For more information, call the Library
at
|
|
|
| The Visually Impaired Service Team The
Visually Impaired Service Team (V.I.S.T.) is a program of comprehensive
services for eligible, legally blind veterans. The purpose of the
program is to ensure that veterans are brought into contact with
the restorative services which can help the individual overcome
the negative effects of blindness. Services include: It is the objective of the V.I.S.T. program to inform veterans and their families about services and benefits available to them through the Department of Veterans Affairs. Additional objectives are to ensure the provision of health care and rehabilitation training to visually impaired veterans and to help the individual in adjustment and management of sight loss. Eligibility will be reviewed by the V.I.S.T. Coordinator to determine the most appropriate treatment plan. A Veteran must be discharged from active military service under other than dishonorable conditions and must be legally blind. For additional information, call the V.I.S.T. program at (401) 273-7100, ext. 3520.
|
|
|
Clinical
Trial for Wet Macular Patients Alcon Laboratories is conducting a phase III multi-center clinical trial for people suffering from vision loss associated with the wet form of Age-related Macular Degeneration. Wet AMD is caused by the growth of abnormal blood vessels in the back of the eye. The clinical trial, which is currently enrolling patients, will compare the safety and effectiveness of an investigational drug, called Anecortave Acetate, to treatment with FDA-approved Visudyne Photodynamic Therapy (PDT) for inhibiting the growth of blood vessels in the back of the eye and maintaining the vision of people with early-stage wet AMD. Over the course of the study, patients will not know whether they are receiving the investigational drug Anecortave Acetate or Visudyne PDT. All patients receive eye exams at no cost. People who have wet AMD and who are age 50 or older may be eligible to participate. To find out if you can be a part of this study, call toll-free 1-866-692-5959. Because Anecortave Acetate is an experimental treatment, Foundation Fighting Blindness and SIGHT LOSS Services do not endorse Anecortave Acetate or suggest that this treatment is a better alternative to standard treatment with PDT. It is highly suggested that patients who are interested in this clinical trial consult their physician. The Foundation Fighting Blindness |
|
|
